Existing Covid vaccines much less effective against Omicron, says Moderna’s chief executive
"I do not think there is a chance that efficiency will be at the same level as we had with Delta," he told the Financial Times
Pfizer BioNTech and Moderna are making $ 65,000 a minute from their Covid-19 vaccines
According to a report by the People’s Vaccine Alliance, In contrast, AstraZeneca and Johnson & Johnson sell their vaccines at a cost price.
German Vaccination Committee advises against Moderna jab for under 30 and pregnant women
The recommendations follow similar ones from the French authority